Relationship between activin A level and infarct size in patients with acute myocardial infarction undergoing successful primary coronary intervention

Clinica Chimica Acta

Volumn 401, Issue 1-2, 2009, Pages 3-7

  Miyoshi, Toru ^a   Hirohata, Satoshi ^a   Uesugi, Tadahisa ^b   Hirota, Minoru ^b   Ohnishi, Hiromichi ^b   Nogami, Kunio ^b   Hatanaka, Kunihiko ^a   Ogawa, Hiroko ^a   Usui, Shinichi ^c   Kusachi, Shozo ^c  

^a OKAYAMA UNIVERSITY   (Japan)

^b KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

Coronary artery disease; Diagnosis; Immunoassay; Inflammation

Indexed keywords

ACTIVIN A; CREATINE KINASE; INTERLEUKIN 6;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION SIZE; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ACTIVINS; AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CREATINE KINASE; CREATINE KINASE, MB FORM; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGRESSION ANALYSIS;

ANGINA;

EID: 58549091073     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.10.027     Document Type: Article

References (35)

1. Sobel B.E., Bresnahan G.F., Shell W.E., and Yoder R.D. Estimation of infarct size in man and its relation to prognosis. Circulation 46 (1972) 640-648
2. White H.D., Norris R.M., Brown M.A., Brandt P.W., Whitlock R.M., and Wild C.J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76 (1987) 44-51
3. Wei J.Y., Markis J.E., Malagold M., and Grossman W. Time course of serum cardiac enzymes after intracoronary thrombolytic therapy. Creatine kinase, creatine kinase MB isozyme, lactate dehydrogenase, and serum glutamic-oxaloacetic transaminase. Arch Intern Med 145 (1985) 1596-1600
4. Hirschl M.M., Gwechenberger M., Binder T., et al. Assessment of myocardial injury by serum tumour necrosis factor alpha measurements in acute myocardial infarction. Eur Heart J 17 (1996) 1852-1859
5. Theroux P., Armstrong P.W., Mahaffey K.W., et al. Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial. Eur Heart J 26 (2005) 1964-1970
6. Mason A.J., Hayflick J.S., Ling N., et al. Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta. Nature 318 (1985) 659-663
7. Ling N., Ying S.Y., Ueno N., et al. Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 321 (1986) 779-782
8. Hubner G., Brauchle M., Gregor M., and Werner S. Activin A: a novel player and inflammatory marker in inflammatory bowel disease?. Lab Invest 77 (1997) 311-318
9. Yu E.W., Dolter K.E., Shao L.E., and Yu J. Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies. Clin Exp Immunol 112 (1998) 126-132
10. Michel U., Ebert S., Phillips D., and Nau R. Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia. Eur J Endocrinol 148 (2003) 559-564
11. Kozaki K., Akishita M., Eto M., et al. Role of activin-A and follistatin in foam cell formation of THP-1 macrophages. Arterioscler Thromb Vasc Biol 17 (1997) 2389-2394
12. Engelse M.A., Neele J.M., van Achterberg T.A., et al. Human activin-A is expressed in the atherosclerotic lesion and promotes the contractile phenotype of smooth muscle cells. Circ Res 85 (1999) 931-939
13. Engelse M.A., Lardenoye J.H., Neele J.M., et al. Adenoviral activin a expression prevents intimal hyperplasia in human and murine blood vessels by maintaining the contractile smooth muscle cell phenotype. Circ Res 90 (2002) 1128-1134
14. Smith C., Yndestad A., Halvorsen B., et al. Potential anti-inflammatory role of activin A in acute coronary syndromes. J Am Coll Cardiol 44 (2004) 369-375
15. Rosalki S.B. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med 69 (1967) 696-705
16. Uesugi T., Iwasaki K., Murakami M., et al. Circulating white blood cell count correlates with left ventricular indices independently of the extent of risk area for myocardial infarction after successful reperfusion. Acta Cardiol 59 (2004) 533-539
17. Horder M., Elser R.C., Gerhardt W., Mathieu M., and Sampson E.J. International Federation of Clinical Chemistry, Scientific Division Committee on Enzymes: approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes. Part 7. IFCC method for creatine kinase (ATP: creatine N-phosphotransferase, EC 2.7.3.2). Eur J Clin Chem Clin Biochem 29 (1991) 435-456
18. Murakami T., Kusachi S., Murakami M., et al. Time-dependent changes of serum carboxy-terminal peptide of type I procollagen and carboxy-terminal telopeptide of type I collagen concentrations in patients with acute myocardial infarction after successful reperfusion: correlation with left ventricular volume indices. Clin Chem 44 (1998) 2453-2461
19. Suezawa C., Kusachi S., Murakami T., et al. Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function. J Lab Clin Med 145 (2005) 33-40
20. Koten K., Hirohata S., Miyoshi T., et al. Serum interferon-gamma-inducible protein 10 level was increased in myocardial infarction patients, and negatively correlated with infarct size. Clin Biochem 41 (2008) 30-37
21. Knight P.G., Muttukrishna S., and Groome N.P. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid. J Endocrinol 148 (1996) 267-279
22. Greene D.G., Carlisle R., Grant C., and Bunnell I.L. Estimation of left ventricular volume by one-plane cineangiography. Circulation 35 (1967) 61-69
23. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 312 (1985) 932-936
24. Rentrop K.P., Thornton J.C., Feit F., and Van Buskirk M. Determinants and protective potential of coronary arterial collaterals as assessed by an angioplasty model. Am J Cardiol 61 (1988) 677-684
25. Foster C.M., Phillips D.J., Wyman T., Evans L.W., Groome N.P., and Padmanabhan V. Changes in serum inhibin, activin and follistatin concentrations during puberty in girls. Hum Reprod 15 (2000) 1052-1057
26. Klein N.A., Houmard B.S., Hansen K.R., et al. Age-related analysis of inhibin A, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women. J Clin Endocrinol Metab 89 (2004) 2977-2981
27. Lin S.D., Kawakami T., Ushio A., et al. Ratio of circulating follistatin and activin A reflects the severity of acute liver injury and prognosis in patients with acute liver failure. J Gastroenterol Hepatol 21 (2006) 374-380
28. Gribi R., Tanaka T., Harper-Summers R., and Yu J. Expression of activin A in inflammatory arthropathies. Mol Cell Endocrinol 180 (2001) 163-167
29. Ebert S., Phillips D.J., Jenzewski P., Nau R., O'Connor A.E., and Michel U. Activin A concentrations in human cerebrospinal fluid are age-dependent and elevated in meningitis. J Neurol Sci 250 (2006) 50-57
30. Yndestad A., Ueland T., Oie E., et al. Elevated levels of activin A in heart failure: potential role in myocardial remodeling. Circulation 109 (2004) 1379-1385
31. Jones K.L., de Kretser D.M., Clarke I.J., Scheerlinck J.P., and Phillips D.J. Characterisation of the rapid release of activin A following acute lipopolysaccharide challenge in the ewe. J Endocrinol 182 (2004) 69-80
32. Jones K.L., Mansell A., Patella S., et al. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci U S A 104 (2007) 16239-16244
33. Wilson K.M., Smith A.I., and Phillips D.J. Stimulatory effects of lipopolysaccharide on endothelial cell activin and follistatin. Mol Cell Endocrinol 253 (2006) 30-35
34. Di Chiara A., Plewka M., Werren M., Badano L.P., Fresco C., and Fioretti P.M. Estimation of infarct size by single measurements of creatine kinase levels in patients with a first myocardial infarction. J Cardiovasc Med (Hagerstown) 7 (2006) 340-346
35. Ahumada G., Roberts R., and Sobel B.E. Evaluation of myocardial infarction with enzymatic indices. Prog Cardiovasc Dis 18 (1976) 405-420